Loading chat...

NY A02145

Bill

Official Source

Status

Introduced

1/15/2025

Primary Sponsor

Karines Reyes

Click for details

Origin

Assembly

2025-2026 General Assembly

AI Summary

  • Allows prescription labels for mifepristone, misoprostol, and generic equivalents to display the dispensing health care practice name instead of the individual dispenser's name
  • Permits prescribers to request that their health care practice name appear on the label rather than their personal name
  • Applies specifically to medication abortion drugs (mifepristone and misoprostol)
  • Amends Education Law sections 6807 and 6810 governing prescription labeling requirements
  • Takes effect immediately upon enactment

Legislative Description

Permits prescription labels for mifepristone, misoprostol, and their generic alternatives to include the name of the prescribing health care practice instead of the name of the prescriber at the prescriber's request.

Last Action

substituted by s36a

1/22/2025

Committee Referrals

Rules1/22/2025
Higher Education1/15/2025

Full Bill Text

No bill text available